FDA/CDC

FDA recalls kratom products for salmonella contamination


 

The Food and Drug Administration on April 3 recalled all products containing kratom manufactured by Triangle Pharmanaturals LLC, after a number of supplements tested positive for salmonella.

The FDA advises consumers to get rid of products including Raw Form Organics Maeng Da Kratom Emerald Green, Raw Form Organics Maeng Da Kratom Ivory White, and Raw Form Organics Maeng Da Kratom Ruby Red.

Evidence of the contamination was found after two samples were collected from a retail store in Oregon by the Oregon Public Health Division and tested positive for salmonella.

ThorPorre/commons.wikimedia.org

The Mitragyna Speciosa tree, from which the drug kratom is produced.

The recall was ordered after Triangle Pharmanaturals did not comply with a March 30 formal request from the FDA to voluntarily recall their products.

“This action is based on the imminent health risk posed by the contamination of this product with salmonella, and the refusal of this company to voluntarily act to protect its customers and issue a recall, despite our repeated requests and actions,” said FDA Commissioner Scott Gottlieb, M.D., said in a statement. “The action today is based on the risks posed by the contamination of this particular product with a potentially dangerous pathogen.”

At press time, Triangle Pharmanaturals did not respond to a request for comment.

Pages

Recommended Reading

Opioids linked to mortality in IBD
MDedge Internal Medicine
Nonopioid analgesics have no major disadvantages vs. opioids for chronic pain
MDedge Internal Medicine
Opioid prescriptions got shorter in 2017
MDedge Internal Medicine
The case for being open-minded about medical marijuana
MDedge Internal Medicine
Intramuscular steroid injection reduced hip OA pain up to 12 weeks
MDedge Internal Medicine
MDedge Daily News: Why the barber’s chair can help hypertension
MDedge Internal Medicine
Abstract: The Opioid Crisis and the Need for Compassion in Pain Management
MDedge Internal Medicine
Is kratom the answer to the opioid crisis?
MDedge Internal Medicine
Abstract: Don't demonise prescription opioids
MDedge Internal Medicine
FDA advisors recommend lofexidine for opioid withdrawal
MDedge Internal Medicine